Managing Moderate Atopic Dermatitis with Rinvoq | Village Dermatology Katy & Houston, TX
By: Dr. Caroline Vaughn
Introduction
Atopic dermatitis (eczema) can persist well into adulthood, impacting both comfort and confidence. At Village Dermatology, we offer advanced treatment options like Rinvoq (upadacitinib), a JAK inhibitor approved for moderate to severe eczema. This case highlights the progress of a 56-year-old woman after four months of Rinvoq therapy.
Case Overview
Patient: 56-year-old female
Condition: Moderate atopic dermatitis
Treatment Duration: 4 months on Rinvoq 30mg daily
History: Atopic dermatitis localized to scalp, with persistent patches on neck, face, shoulder, and forearm
Treatment Progress with Rinvoq
The patient reported:
Significant symptom improvement
No side effects from Rinvoq
Ongoing use of topical medications only for small, resistant areas
๐ Breakthrough Symptoms:
Mild itchy bumps on face and posterior neck
Differential included breakthrough eczema vs. contact dermatitis
Updated Treatment Plan
To manage these residual symptoms and maintain control:
๐ Systemic Therapy (Continued):
Rinvoq 30mg daily
Monitoring risks discussed: infections, cardiovascular events, shingles, malignancy
High-risk medication counseling emphasized
๐งด Topical & Supportive Therapies:
Ketoconazole 2% shampoo โ 2โ3x/week for scalp and face
Clobetasol shampoo โ for flare-ups on scalp
Hydrocortisone 2.5% cream โ short-term use on face
๐งผ Skin Care Counseling:
Lukewarm water bathing
Gentle cleansers (unscented)
Moisturizing 2โ3 times daily
Avoiding scented detergents, handwashing, and scratching
Patient Education
We provided detailed counseling about:
Rinvoq safety: infection risks, cardiovascular monitoring, and need for regular lab testing
Flare-up triggers: stress, seasonal changes, irritants
When to call: if symptoms worsen or signs of infection (e.g., crusting, yellow discharge) occur
Why This Matters in Katy & Houston, TX
Rinvoq is transforming the lives of patients with chronic eczema in areas like Houston and Katy, where humidity and heat often aggravate the condition. Our dermatologists provide comprehensive management, from high-risk medication monitoring to tailored topical therapy.
Follow-Up Plan
The patient will return in 6 months for a routine evaluation and medication monitoring.